Ondine Biomedical Inc (OBI) — Working Capital to Net Assets Ratio
Ondine Biomedical Inc (OBI) has a Working Capital to Net Assets ratio of 90.8% as of December 2024. Working capital of GBX6.24 Million (current assets of GBX12.19 Million minus current liabilities of GBX5.95 Million) is measured against net assets of GBX6.88 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See OBI equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Ondine Biomedical Inc Working Capital to Net Assets (2001–2024)
This chart shows how Ondine Biomedical Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2001 to 2024. As of December 2024, the ratio stands at 90.8%, reflecting working capital of GBX6.24 Million against net assets of GBX6.88 Million GBX. Check Ondine Biomedical Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Ondine Biomedical Inc (2001–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Ondine Biomedical Inc from 2001 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Ondine Biomedical Inc worth.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 90.8% | GBX6.24 Million | GBX6.88 Million | GBX12.19 Million | GBX5.95 Million | ▲ +30.3 pp |
| 2023 | 60.4% | GBX1.26 Million | GBX2.08 Million | GBX4.75 Million | GBX3.49 Million | ▼ -35.9 pp |
| 2022 | 96.4% | GBX11.22 Million | GBX11.64 Million | GBX15.13 Million | GBX3.91 Million | ▼ -3.4 pp |
| 2021 | 99.7% | GBX29.58 Million | GBX29.66 Million | GBX33.50 Million | GBX3.92 Million | ▼ -0.9 pp |
| 2020 | 100.6% | GBX-34.04 Million | GBX-33.83 Million | GBX1.75 Million | GBX35.78 Million | ▼ -5.5 pp |
| 2019 | 106.1% | GBX-27.66 Million | GBX-26.07 Million | GBX1.01 Million | GBX28.67 Million | ▼ -6.2 pp |
| 2018 | 112.3% | GBX-20.11 Million | GBX-17.90 Million | GBX2.29 Million | GBX22.40 Million | ▼ -30.2 pp |
| 2017 | 142.5% | GBX-9.33 Million | GBX-6.55 Million | GBX2.82 Million | GBX12.15 Million | ▲ +309.3 pp |
| 2010 | -166.8% | GBX-465.70K | GBX279.19K | GBX1.64 Million | GBX2.11 Million | ▼ -188.7 pp |
| 2009 | 21.9% | GBX279.44K | GBX1.28 Million | GBX1.56 Million | GBX1.28 Million | ▼ -19.6 pp |
| 2008 | 41.5% | GBX554.68K | GBX1.34 Million | GBX2.05 Million | GBX1.50 Million | ▼ -49.7 pp |
| 2007 | 91.1% | GBX9.88 Million | GBX10.84 Million | GBX11.90 Million | GBX2.01 Million | ▼ -3.7 pp |
| 2006 | 94.9% | GBX15.74 Million | GBX16.59 Million | GBX17.58 Million | GBX1.84 Million | ▼ -2.0 pp |
| 2005 | 96.9% | GBX15.99 Million | GBX16.50 Million | GBX16.69 Million | GBX702.68K | ▼ -3.1 pp |
| 2003 | 100.0% | GBX-227.62K | GBX-227.62K | GBX6.36K | GBX233.99K | ▼ 0.0 pp |
| 2002 | 100.0% | GBX-143.28K | GBX-143.28K | GBX845.00 | GBX144.13K | ▲ +103.6 pp |
| 2001 | -3.6% | GBX-50.17K | GBX1.39 Million | GBX7.84K | GBX58.02K | — |